Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

3.6%

1 terminated out of 28 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

25%

7 trials in Phase 3/4

Results Transparency

50%

6 of 12 completed with results

Key Signals

6 with results92% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (13)
P 1 (2)
P 2 (5)
P 3 (2)
P 4 (5)

Trial Status

Completed12
Unknown5
Not Yet Recruiting3
Recruiting2
Withdrawn2
Active Not Recruiting2

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT07395674Not ApplicableNot Yet Recruiting

Subcutaneous Dexpanthenol Administration and Wound Epithelialization

NCT07449988Not ApplicableNot Yet RecruitingPrimary

Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUs

NCT06652360Not ApplicableCompletedPrimary

Chemical Debridement and Leg Ulcers

NCT06642051Not ApplicableActive Not Recruiting

Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery

NCT02577120Phase 1Active Not Recruiting

Wound Healing Endpoint and Recurrence

NCT06831760Not ApplicableCompletedPrimary

A RCT Evaluating Efficacy of Type-I Collagen Skin Substitute vs. Human Amnion Membrane in Treatment of Venous Leg Ulcers

NCT02422017Phase 2CompletedPrimary

Topical Timolol Benefit in Venous Ulcers

NCT07031180Not ApplicableNot Yet RecruitingPrimary

Educational Interventions in Venous Leg Ulcer

NCT06693570Phase 4Recruiting

Evaluating Intact Fish Skin Graft and Standard of Care Versus Standard of Care Alone in Nonhealing Venous Leg Ulcers

NCT06764953Not ApplicableRecruitingPrimary

Clinical Trial Evaluating an Amnion Membrane Allograft Intended for Use in the Management of Non- Healing Venous Leg Ulcers Versus Standard Of Care Alone

NCT02047084Enrolling By InvitationPrimary

Comparison of Human Allograft to Apligraf for Venous Leg Ulcers

NCT02312518Not ApplicableUnknownPrimary

A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers

NCT02470806Not ApplicableCompletedPrimary

Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)

NCT02609594Not ApplicableUnknownPrimary

Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers

NCT02020746Phase 2Completed

Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds

NCT02352454Not ApplicableUnknownPrimary

Effectiveness of Aurix Therapy in Venous Leg Ulcers

NCT01737762Phase 3CompletedPrimary

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

NCT00953563Not ApplicableWithdrawnPrimary

The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers

NCT02940587Phase 4WithdrawnPrimary

Effectiveness of Aurix Therapy in Venous Leg Ulcers

NCT02154087Phase 2TerminatedPrimary

A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers

Scroll to load more

Research Network

Activity Timeline